Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Cervical Cancer

  Free Subscription


03.11.2025

1 ACS Infect Dis
1 AJOG Glob Rep
2 Am J Obstet Gynecol
1 Arch Biochem Biophys
2 Arch Pathol Lab Med
1 Arkh Patol
6 Asian Pac J Cancer Prev
2 BMC Cancer
1 BMC Infect Dis
2 BMC Public Health
1 BMJ Glob Health
1 Brachytherapy
1 Cancer Biother Radiopharm
3 Cancer Causes Control
1 Cancer Control
1 Cancer Genomics Proteomics
1 Cancer Immunol Immunother
1 Cancer Immunol Res
1 Cancers (Basel)
1 Cell Death Discov
2 Cells
1 Cent Eur J Public Health
2 Curr Oncol
1 Diagn Cytopathol
1 Discov Oncol
1 Environ Toxicol
1 Ethn Health
1 Eur J Cancer Prev
1 Eur Radiol
1 Fam Pract
3 Front Immunol
1 Front Med (Lausanne)
3 Front Oncol
1 Hematol Oncol Clin North Am
2 Hum Vaccin Immunother
1 In Vivo
2 Indian J Pathol Microbiol
1 Infect Agent Cancer
1 Int J Biol Markers
1 Int J Environ Res Public Health
1 Int J Equity Health
1 Int J Gynaecol Obstet
3 Int J Gynecol Cancer
1 Int J Hyperthermia
1 Int J Infect Dis
1 Int J Mol Sci
1 Int J Womens Health
1 Iran J Allergy Asthma Immunol
1 J Biomed Opt
1 J Clin Med
1 J Immunol Methods
1 J Med Virol
1 J Midwifery Womens Health
1 J Natl Cancer Inst
1 J Obstet Gynaecol Res
1 J Pers Med
1 J Pharm Biomed Anal
1 J Proteome Res
1 J Transl Med
1 JCO Glob Oncol
1 Jpn J Radiol
1 Magn Reson Imaging
1 Med Sci Monit
1 Menopause
1 Mol Clin Oncol
1 Naunyn Schmiedebergs Arch Pharmacol
1 Pak J Pharm Sci
1 Pathogens
4 PLoS One
1 Precis Radiat Oncol
2 Sci Rep
1 Support Care Cancer
1 Syst Rev
1 Transl Cancer Res
1 Trop Doct
1 Vaccines (Basel)
2 Viruses
1 Wiad Lek
2 Zhonghua Fu Chan Ke Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    ACS Infect Dis

  1. MEDINA-RIVERO AS, Ratkovich-Gonzalez S, Ruiz-Briseno MDR, Rosas-Gonzalez VC, et al
    The Role of Cervicovaginal Microbiota and Probiotics in Modulating HPV Persistence and Preventing Cervical Cancer.
    ACS Infect Dis. 2025 Oct 29. doi: 10.1021/acsinfecdis.5c00385.
    PubMed         Abstract available


    AJOG Glob Rep

  2. BURAYU ET, Degefa BD, Zegeye ZB, Bekele GG, et al
    Incidence and predictors of mortality among cervical cancer patients in Sub-Saharan Africa: a systematic review and meta-analysis.
    AJOG Glob Rep. 2025;5:100570.
    PubMed         Abstract available


    Am J Obstet Gynecol

  3. SCHAAFSMA M, Schuurman TN, van Maurik IS, Bekkers RLM, et al
    Optimal follow-up strategy using high-risk HPV testing and cytology after conservative treatment for cervical adenocarcinoma in situ.
    Am J Obstet Gynecol. 2025 Jun 5:S0002-9378(25)00367.
    PubMed         Abstract available

  4. ERIKSEN DO, Lycke KD, Kahlert J, Ostenfeld EB, et al
    Active surveillance of cervical intraepithelial neoplasia grade 2 is not associated with an increased risk of non-cervical anogenital HPV-related cancer and precancer a population-based cohort study.
    Am J Obstet Gynecol. 2025 Jun 3:S0002-9378(25)00366.
    PubMed         Abstract available


    Arch Biochem Biophys

  5. GAO Q, Wang Q, Hu Y, Xin F, et al
    SIRT7 deficiency promoted cuproptosis-mediated mitochondrial dysfunction and inhibited malignant development of cervical cancer.
    Arch Biochem Biophys. 2025 Oct 28:110651. doi: 10.1016/j.abb.2025.110651.
    PubMed         Abstract available


    Arch Pathol Lab Med

  6. LU Z, Ali R, Gall R, Velazquez-Miranda E, et al
    Effectiveness of Human Papillomavirus Self-collection for Cervical Cancer Screening in Community Outreach Programs.
    Arch Pathol Lab Med. 2025 Oct 31. doi: 10.5858/arpa.2025-0325.
    PubMed         Abstract available

  7. CHEUNG MA, McKeown CD, McCarthy CM
    Outcomes and Management of Atypical Squamous Cells-Cannot Exclude High-Grade Squamous Intraepithelial Lesion in a Primary Human Papillomavirus Screening System.
    Arch Pathol Lab Med. 2025;149:1022-1026.
    PubMed         Abstract available


    Arkh Patol

  8. KOLINA AD, Danilova NV, Andreeva YY
    [Predictive immunotherapeutic markers of adenocarcinomas and adenosquamous carcinoma of the cervix].
    Arkh Patol. 2025;87:74-79.
    PubMed         Abstract available


    Asian Pac J Cancer Prev

  9. SRIPAN P, Aurpibul L, Srithanaviboonchai K, Tangmunkongvorakul A, et al
    Factors Associated with Suboptimal Screening for Cervical Cancer among Ethnic Women in Thailand-Myanmar Border Area.
    Asian Pac J Cancer Prev. 2025;26:3727-3736.
    PubMed         Abstract available

  10. SUKHABOT K, Jaengpromma P, Praphasawat R, Pimalram P, et al
    Effective Anti-Cancer Activity of Red Rice Bran Extract on Cervical Cancer and Breast Cancer Cells.
    Asian Pac J Cancer Prev. 2025;26:3719-3725.
    PubMed         Abstract available

  11. DILLARD A, Marshall SM, Teneza JN, Kekauoha BP, et al
    The Adoption of Cancer Screening and Prevention in Hawaiian Homestead Communities.
    Asian Pac J Cancer Prev. 2025;26:3691-3697.
    PubMed         Abstract available

  12. ABREFAH E, Agyei-Baffour P, Owusu AB, Commeh ME, et al
    Human Papillomavirus (HPV) Vaccination and Cervical Cancer Prevention: Ghanaian Adolescent Students' Perspectives Through Focus Group Discussion.
    Asian Pac J Cancer Prev. 2025;26:3679-3689.
    PubMed         Abstract available

  13. SHOJAPOUR M, Mosayebi G, Fathi Y, Soleimani H, et al
    In vitro Evaluation of the Combined Effects of a Static Magnetic Field and Curcumin on MCF7 and HeLa Cell Lines.
    Asian Pac J Cancer Prev. 2025;26:3653-3662.
    PubMed         Abstract available

  14. GRACA ADV, Soares LC, Brollo JLA
    Barriers to HPV Vaccination in Brazil: A Systematic Review.
    Asian Pac J Cancer Prev. 2025;26:3549-3560.
    PubMed         Abstract available


    BMC Cancer

  15. ABUBAKAR BG
    Taking it to their doorstep: outreach well-woman clinics in brothels for cervical cancer screening of female sex workers in North-Western Nigeria.
    BMC Cancer. 2025;25:1660.
    PubMed         Abstract available

  16. LI N, Yu Z, Li X, Gao Y, et al
    The rationality of negative margin criteria for conization in early cervical cancer - a cohort study.
    BMC Cancer. 2025;25:1640.
    PubMed         Abstract available


    BMC Infect Dis

  17. COLNEY Z, Laldinmawii G, Singson S, Royte V, et al
    Unveiling the burden of human papillomavirus infection and risk factors among Indigenous women in Mizoram, Northeast India.
    BMC Infect Dis. 2025;25:1406.
    PubMed         Abstract available


    BMC Public Health

  18. QI S, Chen Q, Liang J, Yang X, et al
    Evaluating the quality and reliability of cervical cancer related videos on YouTube, Bilibili, and Tiktok: a cross-sectional analysis.
    BMC Public Health. 2025;25:3682.
    PubMed         Abstract available

  19. ADAM J, Sougou NM
    Cervical cancer screening and its associated factors among women of reproductive age in senegal: evidence from 2023 continuous demographic and health survey in Senegal.
    BMC Public Health. 2025;25:3617.
    PubMed         Abstract available


    BMJ Glob Health

  20. ALFARO K, Lopez L, Soler M, Conzuelo Rodriguez G, et al
    Long-term outcomes after cervical cancer screening in El Salvador: primary human papillomavirus screen-and-treat compared with cytology.
    BMJ Glob Health. 2025;10:e017983.
    PubMed         Abstract available


    Brachytherapy

  21. NAYAK P, Chopra S, Gupta Y, Saahil W, et al
    Radiomics-based machine-learning approach to predict response at brachytherapy using pretreatment magnetic resonance imaging in locally advanced cervical cancer.
    Brachytherapy. 2025 Oct 30:S1538-4721(25)00301.
    PubMed         Abstract available


    Cancer Biother Radiopharm

  22. OZDEMIR BG, Almali DA
    Letter: Comment on "Long Noncoding RNA DLX6-AS1 Promotes the Progression in Cervical Cancer by Targeting miR-16-5p/ARPP19 Axis".
    Cancer Biother Radiopharm. 2025 Oct 24. doi: 10.1177/10849785251392781.
    PubMed        


    Cancer Causes Control

  23. GUETTERMAN TC, Vinson A, Stack M, Alves ML, et al
    Rural women choose self-sampling over a pelvic exam for cervical cancer screening: a mixed-method study.
    Cancer Causes Control. 2025 Oct 27. doi: 10.1007/s10552-025-02081.
    PubMed         Abstract available

  24. ORJI AF, Gimm G, Parekh T, Turpin R, et al
    Disparities in human papillomavirus vaccination uptake across the intersection of disability and sexual orientation.
    Cancer Causes Control. 2025;36:1385-1397.
    PubMed         Abstract available

  25. ABAY H, Cakmak B, Alagoz FM, Uzunlar O, et al
    The relationship between human papillomavirus (HPV) knowledge and HPV vaccine acceptance among women and affecting factors in Turkiye.
    Cancer Causes Control. 2025;36:1249-1262.
    PubMed         Abstract available


    Cancer Control

  26. WU A, Wang S, Wang D, Xue P, et al
    The Infection Status and Distribution of hrHPV in Cervical Lesions Among Overweight Women Referred for Colposcopy: A Cross-Sectional Study.
    Cancer Control. 2025;32:10732748251390954.
    PubMed         Abstract available


    Cancer Genomics Proteomics

  27. MAEMOTO H, Sakihama S, Karube K, Kudaka W, et al
    Genomic Features of Cervical Cancer in Okinawa, Japan: Preliminary Findings From 23 Patients.
    Cancer Genomics Proteomics. 2025;22:1069-1080.
    PubMed         Abstract available


    Cancer Immunol Immunother

  28. WANG X, Wu Y, Huang J, Zong D, et al
    Bispecific antibodies (PD-1/CTLA-4) vs. PD-1 inhibitors with platinum-based chemotherapy+/-bevacizumab as first-line therapy for persistent, recurrent, or metastatic cervical cancer: a retrospective matched cohort study.
    Cancer Immunol Immunother. 2025;74:347.
    PubMed         Abstract available


    Cancer Immunol Res

  29. YOSHIMOTO D, Iuchi H, Taguchi A, Sone K, et al
    Downregulation of HLA Class I Expression Through HLA-A DNA Methylation Is Associated with Reduced CD8+ T Cell Infiltration in Cervical Cancer.
    Cancer Immunol Res. 2025 Oct 27. doi: 10.1158/2326-6066.CIR-25-0594.
    PubMed         Abstract available


    Cancers (Basel)

  30. RACHADECH N, Phookiaw S, Charoenkwan K
    Effect of Conization Prior to Radical Hysterectomy on Overall and Progression-Free Survival in Early-Stage Cervical Cancer: A Propensity Score-Matched Analysis.
    Cancers (Basel). 2025;17:3360.
    PubMed         Abstract available


    Cell Death Discov

  31. XIA M, Yuan L, Chen L, Wen W, et al
    CREB5 promotes nodal metastasis of cervical cancer by regulation of APLN-induced lymphangiogenesis.
    Cell Death Discov. 2025;11:488.
    PubMed         Abstract available


    Cells

  32. HALAS-WISNIEWSKA M, Zawadka P, Arendt W, Izdebska M, et al
    From Adhesion to Invasion: Integrins, Focal Adhesion Signaling, and Actin Binding Proteins in Cervical Cancer Progression-A Scoping Review.
    Cells. 2025;14:1640.
    PubMed         Abstract available

  33. KASHYAP VK, Kenchappa DB, Singh AK, Singh B, et al
    Alcohol Consumption and Cervical Carcinogenesis: Time to Draw Conclusions.
    Cells. 2025;14:1639.
    PubMed         Abstract available


    Cent Eur J Public Health

  34. MILIJASEVIC D, Tamas T, Cankovic S, Ukropina S, et al
    Inequalities in cervical cancer screening use: results of the Serbian National Health Survey.
    Cent Eur J Public Health. 2025;33:155-162.
    PubMed         Abstract available


    Curr Oncol

  35. PEREZ S
    Cervical Cancer Elimination Requires Systems, Trust, and Action.
    Curr Oncol. 2025;32:565.
    PubMed         Abstract available

  36. WANG Y, Zhou X, Xi Y, Lou H, et al
    PET/CT Imaging Characteristics of Gastric-Type Endocervical Adenocarcinoma: Findings from a Small Exploratory Series.
    Curr Oncol. 2025;32:530.
    PubMed         Abstract available


    Diagn Cytopathol

  37. FERREIRA JE, Chiang N, Jing X, Smola B, et al
    In-Depth Assessment of Cytologic Features in 106 Cervical Papanicolaou Tests of Transgender Male Patients on Testosterone: An Institutional Experience.
    Diagn Cytopathol. 2025 Sep 15. doi: 10.1002/dc.70018.
    PubMed         Abstract available


    Discov Oncol

  38. DONG M, Zhang C, Zhang X, Su Y, et al
    Integrated WGCNA retrieval of T-cell exhaustion genes related to radiosensitivity in locally advanced cervical cancer and prediction of immunotherapy efficacy.
    Discov Oncol. 2025;16:1971.
    PubMed         Abstract available


    Environ Toxicol


  39. RETRACTION: Protective Effect of Tretinoin on Cervical Cancer Growth and Proliferation Through Downregulation of pFAK2 Expression.
    Environ Toxicol. 2025 Oct 24. doi: 10.1002/tox.24587.
    PubMed         Abstract available


    Ethn Health

  40. ADEKUNLE TE, Adekunle TB, Thomas S
    Reconstructing trust in preventive care: Black women's perspectives on equity-centered, cervical cancer interventions.
    Ethn Health. 2025 Oct 26:1-18. doi: 10.1080/13557858.2025.2577130.
    PubMed         Abstract available


    Eur J Cancer Prev

  41. DI GIUSEPPE J, Bernardi M, Cicoli C, Terenzi T, et al
    Cervical cancer prevention and colposcopy in pregnancy: a nationwide survey of Italian colposcopists from the Italian Society of Colposcopy and Cervico-Vaginal Pathology.
    Eur J Cancer Prev. 2025 Oct 1. doi: 10.1097/CEJ.0000000000000991.
    PubMed         Abstract available


    Eur Radiol

  42. GUI B, Russo L, Bharwani N, Cunha TM, et al
    European Society of Urogenital Radiology (ESUR) guidelines on MR imaging prior to fertility-sparing treatments in patients with cervical, endometrial, and ovarian cancers.
    Eur Radiol. 2025;35:7244-7259.
    PubMed         Abstract available


    Fam Pract

  43. HAGIU DP, Saquet M, Partouche H, Gilberg S, et al
    Impact of a shared medical decision-making aid on patient decisional conflict regarding human papillomavirus vaccination: a mixed-methods study.
    Fam Pract. 2025;42:cmaf077.
    PubMed         Abstract available


    Front Immunol

  44. SHEN H, Jiang Y, Zhang L, Zheng Q, et al
    Predicting preoperative lymph node status in patients with cervical cancer: development of interpretable machine learning model and support for the biological plausibility.
    Front Immunol. 2025;16:1654332.
    PubMed         Abstract available

  45. XU Y, Gong X, He H, Deng X, et al
    Salvage sequential integrated boost radiotherapy followed by sintilimab-bevacizumab in cervical small-cell carcinoma with >10 brain metastases: A 3-year survivor case report.
    Front Immunol. 2025;16:1590848.
    PubMed         Abstract available

  46. ZHU Q, Yu S
    The role of cGAS-STING signaling in HPV infection and HPV-related cancers.
    Front Immunol. 2025;16:1709613.
    PubMed         Abstract available


    Front Med (Lausanne)

  47. HUANG X, Lu S, Li X, Wu J, et al
    Multi-omics profiling reveals the role of 4-ethylbenzoic acid in promoting proliferation and invasion of cervical cancer.
    Front Med (Lausanne). 2025;12:1591531.
    PubMed         Abstract available


    Front Oncol

  48. CUI Y, Liu Z, Zhang L, Men K, et al
    Construction of a novel cuproptosis-related gene signature for predicting microenvironment, prognosis and therapeutic response in cervical cancer.
    Front Oncol. 2025;15:1532772.
    PubMed         Abstract available

  49. ALSHDAIFAT EH, Sindiani AM, Alhatamleh S, Abu Mhanna HY, et al
    Enhancing cervical cancer diagnosis with ensemble learning and shark optimization algorithm: comparative study of CT and MRI in cervical cancer diagnosis.
    Front Oncol. 2025;15:1608386.
    PubMed         Abstract available

  50. JIANG N, Ping X, Meng Q, Liu Y, et al
    Development, validation, and visualization of a novel nomogram for predicting clinical outcomes of radiotherapy combined with chemotherapy in locally advanced cervical cancer.
    Front Oncol. 2025;15:1668971.
    PubMed         Abstract available


    Hematol Oncol Clin North Am

  51. FOLEY OW, Strom D, Hinchcliff EM
    Advances in Cervical Cancer.
    Hematol Oncol Clin North Am. 2025;39:1121-1137.
    PubMed         Abstract available


    Hum Vaccin Immunother

  52. BERHANU W, Gobbo E, Herzig van Wees S, Hanson C, et al
    Rumors and fears about the HPV vaccine: Perceptions of adolescent girls in government school in Addis Ababa.
    Hum Vaccin Immunother. 2025;21:2578894.
    PubMed         Abstract available

  53. MONTERO-MACIAS R, Adam M, Rouzier R, Bonneau C, et al
    HPV vaccination efficacy in primary and tertiary prevention of vulvar and vaginal HPV-related high grade dysplasia and cancers: A systematic review.
    Hum Vaccin Immunother. 2025;21:2567704.
    PubMed         Abstract available


    In Vivo

  54. TAI CT, Chen YC, Hsieh YH, Lin CL, et al
    Licoricidin Enhances Paclitaxel-induced Apoptosis Through Endoplasmic Reticulum Stress in Human Cervical Cancer Cells.
    In Vivo. 2025;39:3195-3204.
    PubMed         Abstract available


    Indian J Pathol Microbiol

  55. GARIMA, Nambiar K, Mahajan P, Tanveer N, et al
    Invasive stratified mucin-producing carcinoma of the cervix: A case report and review of the literature.
    Indian J Pathol Microbiol. 2025;68:646-649.
    PubMed         Abstract available

  56. ANWER MA, Sinha R, Bharti S, Surabhi, et al
    Clinicopathological association of programmed death-ligand 1 ( PD-L1 ) expression in uterine cervical carcinomas: A cross-sectional observational study.
    Indian J Pathol Microbiol. 2025;68:472-477.
    PubMed         Abstract available


    Infect Agent Cancer

  57. HUANG H, Du C, Liu G
    China's actions for post-political commitment to global strategy to accelerate cervical cancer elimination.
    Infect Agent Cancer. 2025;20:77.
    PubMed         Abstract available


    Int J Biol Markers

  58. LU X, Song P, Chen Q
    lncRNA PAX8-AS1 suppresses cervical cancer development by regulating miR-675-3p/DCN axis.
    Int J Biol Markers. 2025 Oct 28:3936155251386471. doi: 10.1177/03936155251386471
    PubMed         Abstract available


    Int J Environ Res Public Health

  59. MWANGI JH, Mbeje PN, Mtshali GN
    Challenges and Opportunities of Male Partner Involvement in Cervical Cancer Prevention and Control in Central Kenya: A Qualitative Analysis.
    Int J Environ Res Public Health. 2025;22:1575.
    PubMed         Abstract available


    Int J Equity Health

  60. OKYERE J, Aboagye RG, Ahinkorah BO, Essuman MA, et al
    Assessing the socioeconomic inequalities in cervical cancer screening in sub-Saharan Africa: a decomposition analysis.
    Int J Equity Health. 2025;24:297.
    PubMed        


    Int J Gynaecol Obstet

  61. MARSHALL A, Pareja R, Ruzindana K, Bhatla N, et al
    FIGO position statement on the effectiveness and safety of the HPV vaccine.
    Int J Gynaecol Obstet. 2025 Sep 3. doi: 10.1002/ijgo.70506.
    PubMed         Abstract available


    Int J Gynecol Cancer

  62. WANG L, Wei Y, Wu Q
    Correspondence on "Prognostic impact of para-aortic surgical staging in stage IIIC1 cervical cancer according to the FIGO 2018 classification" by El-Baz et al.
    Int J Gynecol Cancer. 2025 Oct 4:102706. doi: 10.1016/j.ijgc.2025.102706.
    PubMed        

  63. EL-BAZ E, Ouldamer L, Touboul C, Lavoue V, et al
    Prognostic impact of para-aortic surgical staging in stage IIIC1 cervical cancer according to the FIGO 2018 classification.
    Int J Gynecol Cancer. 2025;35:102675.
    PubMed         Abstract available

  64. CERDA V, Rimel BJ, Mercer J, Thompson MA, et al
    Exploratory evaluation of the somatic and immunologic landscape of primary and metastatic cervical cancer to better inform future clinical trial development.
    Int J Gynecol Cancer. 2025;35:102677.
    PubMed         Abstract available


    Int J Hyperthermia

  65. FENG S, Wang H, Duan X, Chen S, et al
    Revolutionizing cervical cancer care: the synergistic effects of hyperthermia and machine learning.
    Int J Hyperthermia. 2025;42:2564343.
    PubMed         Abstract available


    Int J Infect Dis

  66. RIOS-MONTEZA P, Solis-Ponce L, Espetia S, Eklund C, et al
    Nationwide implementation and evaluation of an external quality assessment program for HPV screening in Peru.
    Int J Infect Dis. 2025;160:108067.
    PubMed         Abstract available


    Int J Mol Sci

  67. HURJUI RM, Hurjui IA, Butureanu TA, Popovici D, et al
    HPV-Independent Cervical Cancer-A New Challenge of Modern Oncology.
    Int J Mol Sci. 2025;26:10051.
    PubMed         Abstract available


    Int J Womens Health

  68. YANG Y, Sun C, Wang H
    Prediction of Cervical Cancer Progression Leveraging HPV16 Integration-Related Genes.
    Int J Womens Health. 2025;17:3745-3760.
    PubMed         Abstract available


    Iran J Allergy Asthma Immunol

  69. SEDAGHAT S, Nikbakht Brujeni G, Shamsian SAA, Sohrabi Haghdoost N, et al
    Association between HLA-DRB1.2 Genotypic Diversity and Cervical Cancer in Women Infected with the Human Papillomavirus.
    Iran J Allergy Asthma Immunol. 2025;24:643-652.
    PubMed         Abstract available


    J Biomed Opt

  70. JEYACHANDRAN K, Pakirithodiyil MA, Aruldoss K, Lal M, et al
    Development and clinical validation of a clinically translatable non-chip-on-tip transvaginal imaging system (GynoSight v2.0) for early detection of premalignant cervical lesions.
    J Biomed Opt. 2025;30:106002.
    PubMed         Abstract available


    J Clin Med

  71. LEE WH, Kim SC, Park S, Park JW, et al
    EZH2-Mediated PTEN Silencing Promotes AKT-Dependent Afatinib Resistance in Radiation-Resistant Cervical Cancer Cells.
    J Clin Med. 2025;14:7329.
    PubMed         Abstract available


    J Immunol Methods

  72. AL-MADHAGI S, Khashayar P, Volckaert L, Vanfleteren J, et al
    Advancing cervical cancer screening: A novel in-house ELISA assay for the simultaneous detection of p16 and Ki-67.
    J Immunol Methods. 2025 Oct 29:113998. doi: 10.1016/j.jim.2025.113998.
    PubMed         Abstract available


    J Med Virol

  73. GODOY LR, El-Zein M, Cools P, Padalko E, et al
    E6/E7 Similarity to Human Papillomavirus Prototypes and Performance of HPV Testing by Cobas 4800 HPV Test and Anyplex II HPV HR.
    J Med Virol. 2025;97:e70668.
    PubMed         Abstract available


    J Midwifery Womens Health

  74. AGUILAR JS, Holt HK, Beshers C, Baumann K, et al
    Barriers and Facilitators to Colposcopy Follow-up After Abnormal Cervical Cancer Screening: Qualitative Insights From an Urban Health Care Setting.
    J Midwifery Womens Health. 2025 Oct 29. doi: 10.1111/jmwh.70041.
    PubMed         Abstract available


    J Natl Cancer Inst

  75. ZHAO R, Kulasingam S, Alarid-Escudero F, Minihan AK, et al
    Public-health impact of increasing human papillomavirus vaccination and cervical cancer screening.
    J Natl Cancer Inst. 2025 Oct 24:djaf311. doi: 10.1093.
    PubMed         Abstract available


    J Obstet Gynaecol Res

  76. ISHIDERA Y, Iijima T, Aichi M, Ogawara Y, et al
    Efficacy and Safety of Concurrent Chemoradiotherapy as First-Line Treatment for Stage IVB Cervical Cancer: A Single-Center Retrospective Observational Study.
    J Obstet Gynaecol Res. 2025;51:e70119.
    PubMed         Abstract available


    J Pers Med

  77. MELO CPS, Melo AB, Queiroz FR, Costa AP, et al
    Differentially Expressed Genes Identify FIGO Stage II Cervical Cancer Patients with a Higher Risk of Relapse in a Small Cohort.
    J Pers Med. 2025;15:497.
    PubMed         Abstract available


    J Pharm Biomed Anal

  78. BAI H, Seo MG, Choi SY, Khaowroongrueng V, et al
    Validated LC-MS/MS method for cisplatin quantification in plasma, whole blood, and cervical cancer tissue via diethyldithiocarbamate derivatization: Clinical application in cervical cancer.
    J Pharm Biomed Anal. 2025;268:117180.
    PubMed         Abstract available


    J Proteome Res

  79. PANG G, Wang Z, Sun Z, Lv X, et al
    Integrated Proteomics and Metabolomics Profiling Unveils Biomarkers and Immune Characteristics for Pelvic Lymph Node Metastasis in Cervical Cancer.
    J Proteome Res. 2025 Oct 30. doi: 10.1021/acs.jproteome.5c00314.
    PubMed         Abstract available


    J Transl Med

  80. HUANG X, Zhuang Y, Wang R, Qu J, et al
    Colonization by Porphyromonas gingivalis in cervical squamous cell carcinomas promotes metastasis through FimA/CD151/ITGB1 signaling.
    J Transl Med. 2025;23:1166.
    PubMed         Abstract available


    JCO Glob Oncol

  81. SIMS TT, Yoshida-Court K, El Alam MB, Ramatlho P, et al
    Cervical and Tumor-Associated Microbiomes in Botswana Women With and Without HIV With Carcinoma of the Cervix Before and After Definitive Chemoradiation.
    JCO Glob Oncol. 2025;11:e2500036.
    PubMed         Abstract available


    Jpn J Radiol

  82. SAIDA T, Saitoh T, Shikama A, Hayashi M, et al
    Cervical cancer in the modern era: cutting-edge strategies for diagnosis and treatment.
    Jpn J Radiol. 2025 Oct 28. doi: 10.1007/s11604-025-01897.
    PubMed         Abstract available


    Magn Reson Imaging

  83. CUI Y, Li Y, Na J, Lu J, et al
    Integration of radiomics, habitat imaging, and deep learning for MRI-based prediction of parametrial invasion in cervical cancer: A dual-center study.
    Magn Reson Imaging. 2025 Oct 29:110542. doi: 10.1016/j.mri.2025.110542.
    PubMed         Abstract available


    Med Sci Monit

  84. SAGNIC S, Tuncer SF, Tuncer HA, Dogan S, et al
    Comparative Oncologic Outcomes in High-Risk Human Papillomavirus-Positive and -Negative Cervical Intraepithelial Neoplasia.
    Med Sci Monit. 2025;31:e950452.
    PubMed         Abstract available


    Menopause

  85. TAL BLIMAN Y, Rafaeli Yehudai T, Shiber Y, Mor M, et al
    Spontaneous pyometra in postmenopausal women and gynecologic cancer-a preliminary study based on experience of a tertiary medical center.
    Menopause. 2025;32:1022-1027.
    PubMed         Abstract available


    Mol Clin Oncol

  86. XIE X, Guan H, Li M, Gao W, et al
    Advances in exosomal non-coding RNAs in cervical cancer (Review).
    Mol Clin Oncol. 2025;23:104.
    PubMed         Abstract available


    Naunyn Schmiedebergs Arch Pharmacol

  87. YONG X, Xu X, Zhang X, Song R, et al
    The m6 A modification of CDKN2 A inhibites ferroptosis and affects the resistance of cervical squamous cell carcinoma to cisplatin.
    Naunyn Schmiedebergs Arch Pharmacol. 2025;398:15747-15761.
    PubMed         Abstract available


    Pak J Pharm Sci

  88. LIU L, Ma L, Wang Y, Chen Y, et al
    Effect of Baofukang suppository on the relative indexes of epithelial mesenchymal transformation of tumor cells and prognosis in patients with cervical cancer.
    Pak J Pharm Sci. 2025;38:2146-2153.
    PubMed         Abstract available


    Pathogens

  89. BERBER L, Foy O, Cantu J Jr, Ehrenpreis ED, et al
    Patients with Newly Diagnosed Cervical Cancer Should Be Screened for Anal Human Papillomavirus (HPV) and Anal Dysplasia: Results of Cost and Quality Analysis.
    Pathogens. 2025;14:1007.
    PubMed         Abstract available


    PLoS One

  90. YANG S, Liu L, Su Q, Wang J, et al
    Construction of a prognostic prediction model for concurrent radiotherapy in cervical cancer using GEO and TCGA databases with preliminary validation analysis.
    PLoS One. 2025;20:e0334281.
    PubMed         Abstract available

  91. SHIN HJ, Joo J, Yoon JH, Yoo CW, et al
    Correction: Physical Status of Human Papillomavirus Integration in Cervical Cancer Is Associated with Treatment Outcome of the Patients Treated with Radiotherapy.
    PLoS One. 2025;20:e0335489.
    PubMed         Abstract available

  92. YOUNAS S, Malik ZI, Khan MU, Manzoor S, et al
    Identification of novel therapeutic inhibitors against E6 and E7 oncogenes of HPV-16 associated with cervical cancer.
    PLoS One. 2025;20:e0323595.
    PubMed         Abstract available

  93. BEN TAHER Y, Ben Rekaya M, Romdhane E, Miladi B, et al
    HPV testing in cervical cancer formalin-fixed paraffin embedded tissues: Reliability of the Xpert HPV test and high-risk HPV genotypes distribution in Tunisia.
    PLoS One. 2025;20:e0333600.
    PubMed         Abstract available


    Precis Radiat Oncol

  94. WANG JN, Yu X, Gu LN, Liu DM, et al
    Dosimetric and hematological toxicity analyses of bone marrow-sparing intensity-modulated radiation therapy for patients with cervical cancer treated with extended-field radiation therapy.
    Precis Radiat Oncol. 2025;9:96-107.
    PubMed         Abstract available


    Sci Rep

  95. YOSHIDA K, Morita H, Nakai M, Kawamura Y, et al
    Development and validation of predictive model for emesis in cervical cancer patients receiving concurrent chemoradiotherapy based on multi-institutional retrospective study.
    Sci Rep. 2025;15:37508.
    PubMed         Abstract available

  96. AMETA GK, Ramkumar MS, Jenifa G, Sivaramkrishnan M, et al
    Cervical cancer prediction using deformable kernel darknet-53 and depth wise separable convolutional neural networks.
    Sci Rep. 2025;15:37236.
    PubMed         Abstract available


    Support Care Cancer

  97. MANTERYS K, Blazek M, Kowalczyk A
    Type of treatment, operated organ and sexual functioning of patients with cervical cancer.
    Support Care Cancer. 2025;33:1004.
    PubMed         Abstract available


    Syst Rev

  98. PILLAY J, Gates A, Guitard S, Zakher B, et al
    Screening for the prevention and early detection of cervical cancer: systematic reviews to inform an update to recommendations by the Canadian Task Force on Preventive Health Care.
    Syst Rev. 2025;14:206.
    PubMed         Abstract available


    Transl Cancer Res

  99. WANG H, Liu J, A X, Wang J, et al
    CMTM4 overexpression inhibited tumor growth through regulating the function of myeloid-derived suppressor cells in the cervical cancer microenvironment.
    Transl Cancer Res. 2025;14:5490-5503.
    PubMed         Abstract available


    Trop Doct

  100. PANDEY M, Shanmugham D, Palani R, Nagarajan P, et al
    Pelvic organ prolapse and cervical adenocarcinoma in a postmenopausal woman: A case report.
    Trop Doct. 2025;55:344-346.
    PubMed         Abstract available


    Vaccines (Basel)

  101. LASIC M, Ostrbenk A, Smrkolj S, Bohinc KB, et al
    Prevalence of High-Risk Human Papillomaviruses (HPV) in Slovenian Women Attending Organized National Cervical Cancer Screening 14 Years After Implementation of the National HPV Vaccination Program.
    Vaccines (Basel). 2025;13:1050.
    PubMed         Abstract available


    Viruses

  102. PRUSKI D, Millert-Kalinska S, Jach R, Zurawski J, et al
    Impact of Vaccinating Adult Women Who Are HPV-Positive or with Confirmed Cervical SIL with the 9-Valent Vaccine-A Systematic Review.
    Viruses. 2025;17:1377.
    PubMed         Abstract available

  103. TAMAI K, Kinjo S, Taguchi A, Nagasaka K, et al
    Elucidating Alterations in Viral and Human Gene Expression Due to Human Papillomavirus Integration by Using Multimodal RNA Sequencing.
    Viruses. 2025;17:1344.
    PubMed         Abstract available


    Wiad Lek

  104. HOLOVANOVA IA, Vovk OY, Mats TP, Filatova VL, et al
    Medical and social substantiation of early detection and prevention of visual forms of cervical cancer.
    Wiad Lek. 2025;78:1777-1788.
    PubMed         Abstract available


    Zhonghua Fu Chan Ke Za Zhi

  105. LI JJ, Guan WY, Chu CZ, Chen YY, et al
    [Potential value of HPV integration testing in a triage management for HPV-positive women].
    Zhonghua Fu Chan Ke Za Zhi. 2025;60:788-797.
    PubMed         Abstract available


  106. [Expert consensus on diagnosis and treatment of neuroendocrine carcinoma of the cervix (2025)].
    Zhonghua Fu Chan Ke Za Zhi. 2025;60:753-762.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.